# Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin

> **NCT05915871** · PHASE1 · COMPLETED · sponsor: **Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tegoprazan
- **DRUG:** Bismuth
- **DRUG:** Amoxicilli
- **DRUG:** Clarithromycin

## Key facts

- **NCT ID:** NCT05915871
- **Lead sponsor:** Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-23
- **Primary completion:** 2023-04-28
- **Final completion:** 2023-04-28
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05915871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05915871, "Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05915871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*